Status:
COMPLETED
CyberKnife for Prostate Cancer Patients Aged 70 y or More
Lead Sponsor:
Centre Francois Baclesse, Luxembourg
Conditions:
Prostate Cancer
Eligibility:
MALE
70+ years
Brief Summary
Robotic Stereotactic Radiation treatment of prostatic adenocarcinoma of the elderly. Inclusion criteria : T1-T3b, MRI pelvic nodes negative, M0, any Gleason Score, PSA (Prostate Specific Antigen) \<3...
Detailed Description
Robotic Stereotactic Radiation treatment of prostatic adenocarcinoma of the elderly. Rationale : Half of the prostatic adenocarcinoma are diagnosed in the elderly but until now curative treatments we...
Eligibility Criteria
Inclusion
- T1-T3b,
- MRI pelvic nodes negative,
- M0,
- any Gleason Score,
- PSA\<30ng/ml,
- WHO (World Health Organisation) score\<2, IPSS≤15,
- maximal urinary flow rate ≥15ml/s,
- mean urinary flow rate ≥5ml/s,
- multiparametric prostatic and pelvis MRI
Exclusion
- Prostatic volume \> 100cc,
- TURP (transurethral prostatectomy) \<3 y,
- any recurrent prostatitis within the last 3 years,
- collagenose diseases,
- ulcero-haemorrhagic rectocolitis or
- crohn diseases
Key Trial Info
Start Date :
October 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2021
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT03235557
Start Date
October 1 2014
End Date
December 1 2021
Last Update
June 22 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Francois Baclesse
Esch-sur-Alzette, Luxembourg, 4005